Plain-English translation of NCT06923007 on ClinicalTrials.gov β Β· Source last updated Β· Translation generated Β· How we translate trials
This study doesn't follow the usual testing phases β it may be an observational study or a different type of research.
This study is testing vagus nerve stimulation (VNS)βa surgical procedure that implants a small device to gently stimulate a major nerve in your neckβas a potential treatment for mild to moderate Alzheimer's disease. Researchers want to see whether this treatment can help improve memory, thinking, mood, and daily functioning compared to a sham (fake) version of the procedure. You would receive the implant and then be randomly assigned to either active stimulation or sham stimulation for 6 months while continuing your regular Alzheimer's medications.
Current medications for Alzheimer's disease have limited benefits for many people. This trial explores whether vagus nerve stimulation might offer a new way to slow cognitive decline and improve quality of life in people with early to moderate memory loss.
You likely qualify ifβ¦
You likely don't qualify ifβ¦
You would first undergo screening tests including medical exams, memory assessments, blood work, and brain imaging to confirm you are eligible. If you qualify, you would have surgery to implant the vagus nerve stimulation device. After surgery, you would be randomly assigned to either receive active stimulation or sham stimulation for 6 months. During this time, you would attend clinic visits at baseline, 3 months, and 6 months to have your memory, mood, and daily functioning assessed. Some visits may include additional tests like brain scans or blood draws to help researchers understand how the treatment is working.
AI-generated summary from trial data Β· Jun 7, 2026 Β· Not medical advice
China